
Sorrento Therape is a biotechnology & medical research business based in the US. Sorrento Therape shares (SRNE) are listed on the NASDAQ and all prices are listed in US Dollars. Sorrento Therape employs 799 staff and has a trailing 12-month revenue of around $60.3 million.
How to buy Sorrento Therape stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SRNE. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Sorrento Therape stock price (NASDAQ: SRNE)
Use our graph to track the performance of SRNE stocks over time.Sorrento Therape shares at a glance
Latest market close | $0.37 |
---|---|
52-week range | $0.16 - $3.09 |
50-day moving average | $0.77 |
200-day moving average | $1.55 |
Wall St. target price | $13.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.53 |
Buy Sorrento Therape stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Sorrento Therape stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Sorrento Therape price performance over time
Historical closes compared with the close of $0.3701 from 2023-03-20
1 week (2023-03-14) | 19.50% |
---|---|
1 month (2023-02-21) | -5.10% |
3 months (2022-12-21) | -55.52% |
6 months (2022-09-21) | -77.43% |
1 year (2022-03-21) | -85.25% |
---|---|
2 years (2021-03-19) | -96.13% |
3 years (2020-03-20) | 2.05 |
5 years (2018-03-21) | 8.1 |
Sorrento Therape financials
Revenue TTM | $60.3 million |
---|---|
Gross profit TTM | $-167,049,000 |
Return on assets TTM | -36.87% |
Return on equity TTM | -378.92% |
Profit margin | 0% |
Book value | $0.29 |
Market capitalisation | $168.4 million |
TTM: trailing 12 months
Sorrento Therape share dividends
We're not expecting Sorrento Therape to pay a dividend over the next 12 months.
Have Sorrento Therape's shares ever split?
Sorrento Therape's shares were split on a 1:25 basis on 31 July 2013. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Sorrento Therape shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Sorrento Therape shares which in turn could have impacted Sorrento Therape's share price.
Sorrento Therape share price volatility
Over the last 12 months, Sorrento Therape's shares have ranged in value from as little as $0.161 up to $3.09. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sorrento Therape's is 1.9435. This would suggest that Sorrento Therape's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Sorrento Therape overview
Sorrento Therapeutics, Inc. , a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system. Its clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft versus host disease. The company develops resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for late stage cancer and osteoarthritis knee pain treatment; and ZTlido, a lidocaine delivery system for the treatment of postherpetic neuralgia. It engages in the development of SEMDEXA, an injectable viscous gel formulation, which is Phase III trial for the treatment of sciatica, a pathology of low back pain; SP-103, an investigational non-aqueous lidocaine topical system undergoing clinical development in chronic low back pain condition; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia.
Sorrento Therape in the news
Scilex Holding Company and CH Trading Group Announce Territory Distribution Agreement to Expand Commercialization of ZTlido® for the Middle East and North Africa (MENA) With $105 Million Minimum Multi-Year Purchase Commitment
Is a Surprise Coming for Sorrento Therapeutics (SRNEQ) This Earnings Season?
Scilex Holding Company announces the commercial launch of ELYXYBTM (celecoxib oral solution) in the U.S., strengthening its leadership position in non-opioid pain management
Frequently asked questions
What percentage of Sorrento Therape is owned by insiders or institutions?Currently 1.314% of Sorrento Therape shares are held by insiders and 42.806% by institutions. How many people work for Sorrento Therape?
Latest data suggests 799 work at Sorrento Therape. When does the fiscal year end for Sorrento Therape?
Sorrento Therape's fiscal year ends in December. Where is Sorrento Therape based?
Sorrento Therape's address is: 4955 Directors Place, San Diego, CA, United States, 92121 What is Sorrento Therape's ISIN number?
Sorrento Therape's international securities identification number is: US83587F2020 What is Sorrento Therape's CUSIP number?
Sorrento Therape's Committee on Uniform Securities Identification Procedures number is: 74838K306
More guides on Finder
-
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
-
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
-
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
-
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Ask an Expert